Find Academic Supervisors

Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.

• Proteomics
• Quantitative Mass Spectrometry
• Cell Biology
• +11 more

Elvis Genbo Xu is an Associate Professor at the Department of Biology, University of Southern Denmark. His research focuses on environmental toxicology, particularly micro/nanoplastics and crude oil pollutants. He employs transcriptomics and bioinformatics to study marine ecosystems and embryonic model systems. University of Southern Denmark Department of Biology Active since at least 2018 Research Interests: Micro/Nanoplastics Crumb Rubber Marine Protected Areas Endocrine Disruptors Transcriptomics Bioinformatics Article Trends (2018-2019): Focus on nanoplastics and microplastics Environmental impact assessment Toxicity mechanisms in aquatic organisms Methodological innovations in plastic analysis Interdisciplinary approaches combining toxicology, materials science, and molecular biology Scientific Recognition: 2024 World's Top 2% Scientists 2023 Undervisningsprisen på Naturvidenskab 2021 Faculty Research Dissemination Prize 2020 Best ES&T Letters Paper Advising & Editorial Roles: Active PhD/Postdoc supervision Junior Editor at Journal of Hazardous Materials (2020) Editorial Board member for Environment International (2022)

• Environmental Pollution
• Micro/Nanoplastics
• Crude Oil Toxicology
• +8 more

Lars Aagaard is an Associate Professor at the Department of Biomedicine - Research and Education, Aarhus University, Denmark. He is based at the Bartholin Building in Aarhus C and is actively engaged in research and teaching in the fields of gene therapy, RNA interference, and genome editing. His work focuses on developing viral vectors, particularly AAV and lentiviral vectors, for ocular gene therapy targeting retinal diseases such as age-related macular degeneration and diabetic retinopathy. His research interests include the development of Dicer-independent RNAi systems, combinatorial gene therapy using microRNA and CRISPR/Cas9, and the delivery of RNA- and protein-based therapeutics. He also teaches Genetics and Personalized Medicine and supervises postdoctoral researchers, PhD, master's, and undergraduate students. The recent publications (2022–2024) reflect a strong trend in RNAi therapeutics, viral vector engineering, and translational applications in ocular and systemic diseases. Themes include gene silencing, immune modulation, and regenerative approaches using engineered cells. Aagaard actively contributes to the scientific community as a reviewer for journals such as Nature and Molecular Therapy . He has participated in key international conferences including ARVO, ASGCT, and ESGCT, demonstrating ongoing engagement with the global gene therapy community. Supervision of postdocs, PhD, master’s, and undergraduate students Active participation in international conferences and workshops Collaborative research across institutions, including Universidade Federal de Sao Paulo He is involved in both basic and translational research, with potential for clinical applications in gene and cell therapy.

• Gene therapy
• RNA interference
• Viral vectors
• +11 more

Søren Feddersen serves as an Associate Professor in the Department of Clinical Research at the University of Southern Denmark's Faculty of Health Sciences, with dual appointments at Odense University Hospital (OUH) and the Research Unit of Clinical Biochemistry in Odense. His work bridges laboratory science and clinical applications through biomarker discovery across multiple disease domains. His research centers on molecular mechanisms in cardiovascular pathology, cancer progression, and infectious disease diagnostics , with particular expertise in microRNA profiling , genetic variant analysis , and cytokine signature identification . Current projects investigate JAK2 mutations in aortic aneurysms, pharmacogenomics in breast cancer treatment, and novel biomarkers for prostate cancer and tuberculosis diagnosis. Recent publications (2024-2025) demonstrate a strong translational focus through population-based cohort studies and diagnostic validation trials , frequently involving multi-center collaborations across cardiology, oncology, and immunology. His work consistently emphasizes clinically applicable biomarker discovery using plasma, blood, and tissue samples. Dr. Feddersen has supervised at least one Ph.D. thesis as indicated by institutional records. His collaborative network spans Karolinska Institutet (KI), Odense University Hospital, and international research teams, reflecting engagement in large-scale funded projects though specific grant details aren't publicly itemized. He operates within the Research Unit of Clinical Biochemistry at OUH, contributing to SDU's clinical research infrastructure through interdisciplinary teams focused on molecular diagnostics and precision medicine applications.

• Molecular Biology
• Clinical Biochemistry
• Cancer Research
• +3 more

Vignesh Ramesh is a Research Assistant in Translational Biology at the Department of Biochemistry and Molecular Biology , University of Southern Denmark. His research focuses on metabolic pathways in cancer biology, particularly non-small cell lung cancer (NSCLC) and triple-negative breast cancer (TNBC), with an emphasis on Epithelial-Mesenchymal Transition (EMT) and CRISPR/Cas9 applications. He has contributed to 15+ peer-reviewed publications and media-featured studies on metabolic inhibitors for cancer therapy.

• Cancer Biology
• Biochemistry
• Molecular Biology
• +8 more

Mette Sørensen is an Associate Professor at the Institute for Health Services Research within the Faculty of Health Sciences at the University of Southern Denmark. She leads research in genetic epidemiology, aging, longevity and functional genomics. With a Master of Science and PhD, her academic career has focused on understanding the molecular mechanisms of aging through twin studies and multi-omics approaches. Her research interests center on genetic and epigenetic factors influencing aging processes, with specific expertise in DNA methylation, epigenetics, and twin study methodologies. Sørensen's work examines how genetic and molecular biological factors affect aging trajectories, longevity, and age-related diseases. She applies multi-omics approaches including epigenomics, proteomics, and metabolomics to identify biomarkers of aging and longevity. Dr. Sørensen's recent publications demonstrate a strong focus on epigenetic clocks, DNA methylation patterns in aging, cardiovascular health in relation to molecular markers, and the use of twin studies to disentangle genetic and environmental influences on aging. Her work spans from basic molecular mechanisms to clinical applications in gerontology. Her scientific achievements have been recognized with prestigious awards including the Manufacturer Vilhelm Pedersen and Wife's Memorial Grant from the Novo Nordisk Foundation and The Danish Council for Independent Research Postdoctoral Fellowship. As an active researcher, Sørensen serves as a peer reviewer for journals including Scientific Reports and Aging Cell, participates in major conferences like The Gerontological Society of America Annual Scientific Meeting, and contributes to significant research projects such as LLFS: Længe Leve - et Familiestudie (Long Life Study). She also engages with the public through media interviews about DNA methylation age, aging, and longevity research.

• Genetic Epidemiology
• Aging Research
• Longevity Studies
• +5 more

Henrik Elvang Jensen is a Professor of Veterinary Pathology at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Veterinary and Animal Sciences, Pathobiological Sciences section. He holds appointments at Ridebanevej 9, 1870 Frederiksberg C, Denmark, and serves as Head of the Section of Pathology. His professional credentials include DVM (1984), PhD (1988), DVSci (1994), and DECVP (1996). His research focuses on infectious diseases and inflammatory reactions in animals, particularly pathogenetic and diagnostic studies of bacterial and fungal infections in animal models (primarily mice and pigs). With over 250 peer-reviewed publications, he has established expertise in veterinary pathology related to production animals. His recent work (2025) demonstrates continued activity in porcine wound models, omphalitis in piglets, peri-prosthetic joint infections, and forensic pathology applications. His research spans veterinary pathology, infectious disease mechanisms, and diagnostic methodologies with specific emphasis on bacterial and fungal pathogens. He employs animal models including pigs, mice, and equines to investigate wound healing, infection dynamics, and inflammatory responses. His work bridges basic pathology with practical applications in meat inspection, animal welfare, and forensic veterinary medicine. Diplomate of the European College of Veterinary Pathologists (1997) Fellow of the European Confederation of Medical Mycology (2020) Member of European Food Safety Authority since 2011 Professor Jensen has supervised 16 PhD projects as principal supervisor and 28 as co-supervisor since 1994. He has led research projects funded by private companies, national research councils, and EU institutions. His teaching encompasses veterinary students, biotech students, and human biology students, covering special veterinary pathology through practicals (necropsy, histopathology) and lectures. He regularly provides courses in forensic pathology and meat inspection at various levels. His diagnostic work includes over 25 years of necropsies and histopathological examinations on domestic mammals and laboratory animals.

• Veterinary Pathology
• Infectious Diseases
• Bacterial Infections
• +4 more

Nicolas Julien Fossat serves as an Associate Professor in the Department of Immunology and Microbiology at the Faculty of Health and Medical Sciences, University of Copenhagen. His research spans virology, RNA biology, and developmental biology with a particular focus on viral-host interactions and molecular mechanisms of disease. His research interests primarily focus on RNA biology and virology, with significant contributions to understanding viral RNA modifications, microRNA interactions in viral infections, and the molecular mechanisms of viral replication. His work on Hepatitis C virus RNA capping with flavin adenine dinucleotide represents a major discovery in the field of virology. Additionally, his research extends to developmental biology, particularly in understanding transcription factor networks like TWIST1 in cell differentiation processes. Analysis of his recent publications reveals a strong emphasis on RNA-virus interactions, particularly with flaviviruses including Hepatitis C, yellow fever, and tick-borne encephalitis viruses. His work on SARS-CoV-2 microRNA interactomes during the pandemic demonstrates his ability to pivot research toward emerging health threats. His publications in high-impact journals including Nature, Nature Communications, and Cell Reports highlight the significance of his contributions to the field. Fossat has established productive collaborations with prominent researchers including Bukh, Scheel, and Ramirez, resulting in multiple high-impact publications. His work has received substantial attention, with several papers being highlighted in news outlets and social media platforms, indicating the broader impact of his research.

• Virology
• RNA Biology
• MicroRNA Research
• +5 more

Betina Lyngfeldt Henriksen is a PhD Researcher at the Department of Biotechnology and Biomedicine , Technical University of Denmark , specializing in antiviral immunology and biomedical research. Her work bridges immunology, virology, and veterinary science with a translational focus on infectious diseases and regenerative therapies. Research areas include Influenza A virus , Bacillus subtilis immunomodulation, mesenchymal stem cells , and dendritic cell glycoengineering . Key techniques involve multi-omics analysis , porcine and equine models , and microRNA profiling .

• Immunology
• Virology
• Veterinary Science
• +3 more

Sakari Kauppinen is a Professor at the Department of Clinical Medicine, Faculty of Medicine, Aalborg University. His research focuses on microRNA biology, therapeutic applications, and their roles in diseases such as cancer, neurodegeneration, and metabolic disorders. He leads projects like the 2024 initiative exploring microRNA-22’s role in Duchenne Muscular Dystrophy. Notable contributions include pioneering microRNA-targeted drugs and advancing antisense oligonucleotide technologies. His work spans from basic RNA mechanisms to clinical translation, with collaborations in drug development and biomarker discovery. Kauppinen’s team is part of the Center for RNA Medicine, emphasizing interdisciplinary research in RNA-based therapies. Education details are not explicitly stated, but his career reflects advanced expertise in molecular biology and pharmacology. Key research interests include RNA interference mechanisms, microRNA regulatory pathways, and their modulation in disease contexts. He has authored over 70 publications, including seminal reviews on microRNA therapeutics and patents for innovative nucleic acid compounds. Media highlights include discussions on RNA medicine’s potential post-Nobel recognition and contributions to grants like the Novo Nordisk Foundation funding. Labs/Teams: Active member of the Center for RNA Medicine at Aalborg University. Collaborative projects involve institutions globally, focusing on translational RNA research.

• MicroRNA Therapeutics
• RNA Biology
• Cancer Biology
• +3 more

Thorkell Gudjónsson is an Assistant Professor at the Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen, where he leads research within the Sørensen Group. His work primarily focuses on genome stability mechanisms and their implications in cancer development. Dr. Gudjónsson's research interests center on DNA damage response pathways, chromatin biology, and molecular mechanisms underlying cancer development. His work bridges basic molecular biology with translational cancer research, particularly in breast cancer and other malignancies. He investigates how genome maintenance pathways function under normal conditions and how their dysregulation contributes to carcinogenesis. Analysis of his publication record reveals a consistent focus on DNA repair mechanisms and their relationship to cancer. His most recent work (2024-2025) has centered on tumor suppressors in breast cancer, replication stress disorders, and cytoskeletal proteins that maintain genome integrity. Earlier work established foundational knowledge about chromatin modifications during DNA damage response, with highly cited papers in Cell and Molecular Cell. His research has generated significant scientific impact, with several papers accumulating hundreds of citations, particularly his 2012 Cell paper on TRIP12 and UBR5 which has received over 300 citations. His work appears in high-impact journals including Cell, Nature Communications, and The Journal of Clinical Investigation. As a principal investigator within the Sørensen Group at BRIC, Dr. Gudjónsson collaborates extensively with researchers across multiple institutions, with particular strength in interdisciplinary cancer research combining molecular biology, genetics, and clinical medicine. His laboratory employs advanced techniques in molecular and cellular biology to investigate fundamental mechanisms of genome maintenance.

• DNA damage response
• Genome maintenance
• Cancer biology
• +5 more

Nicole Schmitt is an Associate Professor at the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen (UCPH). She serves as Professor with special responsibilities within Blended Learning and Engagement in Education, and has held continuous academic positions since 2002, including tenured Associate Professor (2012-2017) and Junior Group Leader roles. Her educational background includes a PhD (Dr. rer. nat.) in Ion Channel Research from the University of Hamburg (1997-2000) and an MSc in Biochemistry from the University of Hannover, Germany (1990-1996). Dr. Schmitt's research focuses on the physiology of ion channel complexes, with particular emphasis on structure/function analysis of voltage-gated potassium channels, molecular basis of channelopathies, and elucidation of protein-protein interactions within macromolecular channel protein complexes. Her work aims at understanding mechanisms leading to ion channel diseases by studying ion channel function in cellular contexts, regulatory mechanisms, and pharmacological manipulation. She employs molecular biology and protein-biochemistry methodologies to investigate cardiac arrhythmias, particularly atrial fibrillation and Long QT syndrome. Her recent publications reveal a strong translational focus on cardiac channelopathies, examining genetic variants, molecular mechanisms, and potential therapeutic approaches through both basic and clinical research. Fondsbørsvekselerer Henry Hansen og Hustrus Award 2012 for project "Pathogenesis and treatment of atrial fibrillation" Gerda and Aage Haensch Award 2012 for project "Patient-specific pluripotent stem cell models for atrial fibrillation" Dr. Schmitt serves as main supervisor for undergraduate and graduate students and supervisor of PhD projects across multiple programs including Medicine, Molecular Biomedicine, and Public Health. She has secured research funding through various projects, including an Innovation Fund Denmark project on "Safe and effective pharmacological treatment for atrial fibrillation" (2014-2018), and has been actively involved in academic mentorship programs for assistant professors and postdocs. She leads the Schmitt Group (Ion Channel Group) at the University of Copenhagen, which investigates ion channel complexes and their role in cardiac function and disease through molecular, cellular, and translational approaches, collaborating with institutions worldwide and maintaining strong ties with the Danish National Research Foundation Centre for Cardiac Arrhythmia.

• Physiology of ion channel complexes
• Structure/function analysis of voltage-gated potassium channels
• Molecular basis of channelopathies
• +3 more

Riccardo Panella is a Clinical Associate Professor at the Clinical Institute within Aalborg University's Faculty of Health Sciences and affiliated with the Center for RNA Medicine . His research focuses on microRNA biology, metabolic homeostasis, and RNA-based therapies. Current Role: Clinical Associate Professor, Aalborg University Key Research Areas: microRNA-22 regulation, lipid metabolism, Duchenne Muscular Dystrophy, antisense oligonucleotides, environmental RNA responses Research Highlights: Dr. Panella investigates microRNA-22's role in metabolic and genetic disorders, including Duchenne Muscular Dystrophy and metabolic dysfunction-associated steatotic liver disease. His work spans RNA regulation , mouse models , and biomarker development . Publication Trends: Recent articles emphasize microRNA-22's impact on lipid homeostasis, immunostimulatory responses to antimiR-22, and environmental stress responses in RNA signatures. Collaborative studies involve metabolic imaging , long non-coding RNAs , and transgenic mouse models . Advising: Supervising Tomasini, S. in a PhD project on microRNA-22 in Duchenne Muscular Dystrophy (2024–2025).

• Molecular Biology
• Genetics
• Biomedical Research
• +5 more

Babukrishna Maniyadath is a Researcher at the University of Southern Denmark (SDU), affiliated with the Susanne Mandrup Lab. He holds a PhD from the Tata Institute of Fundamental Research (TIFR), Mumbai, India (2020), and specializes in metabolic regulation, epigenetics, and adipose tissue biology. His current research focuses on adipose tissue plasticity during obesity development and regression, employing single-cell transcriptomics, cytometry, and primary cell culture techniques. Key research themes include molecular mechanisms governing in-vivo adipogenesis under high-fat diets, metabolic oscillations in liver physiology, and the interplay between nutrient signaling and epigenetic modifications. Dr. Maniyadath's work bridges basic science with translational applications in obesity and metabolic disorders. Publications emphasize single-cell resolution analysis of adipose tissue dynamics, chromatin regulation under metabolic stress, and SIRT1/SIRT6 signaling pathways. His research has implications for understanding obesity pathogenesis and developing therapeutic strategies targeting metabolic plasticity. No scientific awards are explicitly listed. He collaborates with the Mandrup Lab on projects involving functional genomics and metabolism, contributing to the ATLAS project's adipose tissue atlas initiative.

• Metabolic Regulation
• Epigenetics
• Adipose Tissue Biology
• +3 more

Rikke Bæk is a Civilingeniør (Chartered Engineer) at Aalborg University Hospital, affiliated with The Faculty of Medicine and Department of Clinical Immunology. She maintains an active research profile with 115 documented publications spanning from 2013 to 2025. Her research focuses on small extracellular vesicles and their clinical applications, particularly in: Analysis of vesicles from dried blood spots for diagnostic purposes Development of microarray analyzers for predicting obstetric syndromes Characterization of vesicles in ovarian cancer diagnostics Blood plasma biomarker discovery Bæk's recent 2025 publications demonstrate continued innovation in vesicle-based diagnostics, with significant attention to translating research into clinical applications. Her fingerprint analysis reveals strong specialization in Small Extracellular Vesicles (100%), Blood Plasma (88%), CD9 (86%), Phenotype (79%), and Surface Property (78%) research. Her work has garnered measurable impact, including 3 Scopus citations for her obstetric syndromes research and news mentions for her dried blood spot analysis. She actively collaborates internationally, contributing to datasets like the Comparative and Integrated Analysis of Plasma Extracellular Vesicles Isolation Methods through the University of Oxford.

• Small Extracellular Vesicles
• Blood Plasma Analysis
• Extracellular Vesicle Biomarkers
• +3 more